Harvard University spinout Ligon Discovery has appointed Errol De Souza as executive chairman of the board. De Souza has held senior-level R&D and management positions at Aventis, Hoechst Marion Roussel, DuPont Merck, Neurocrine Biosciences, Synaptic Pharmaceuticals, and Archemix.
Enzo Biochem said that it has terminated Shahram Rabbani's services as the company's secretary and treasurer, effective immediately. He will continue to serve as a director of the firm, though.
Enzo said that its Chairman and CEO Elazar Rabbani will serve as secretary, while President and CFO Barry Weiner will serve as treasurer.